HOME >> BIOLOGY >> NEWS
Phase Out Planned For One Of Top Five U.S. Pesticides, Plant Doctors Respond

ST. PAUL, Minn., Feb. 17, 1998--The EPA, acting under the Clean Air Act, will be phasing out methyl bromide in just three years, with all U.S. production and importation ending on January 1, 2001. Considerable research indicates methyl bromide a fumigant against weeds, insects, nematodes and microorganisms is a potent ozone depletor. The phase out leaves the agricultural industry in a transitional situation, looking for alternatives.

In response, plant pathologists are hard at work testing new management practices for disease control, especially in tomatoes and strawberries. "The phase out of methyl bromide in the U.S. has stimulated a great deal of creative research," says Jean Beagle Ristaino, associate professor of plant pathology at North Carolina State University and member of the American Phytopathological Society (APS). Her research has led to improvements in the management of soilborne plant pathogens by encouraging the use of ecologically-based strategies.

Use of practices that are less dependent on single-chemical strategies and more biologically and culturally focused may lead to long-term success. Promising tactics include:

  • The use of other fumigants (methyl iodide has some promise and has not been implicated as an ozone depletor)
  • Development of plant varieties resistant to diseases methyl bromide prevented
  • Changes of cultural practices that increase the organic matter level of soil
  • Soil solarization (the thermal heating of moist soil by sunlight)
  • Electrical heating of soil
  • Incorporation of biological control organisms

What ever the alternative, "The loss of methyl bromide certainly presents a significant challenge to American agriculture," says Bill Thomas, EPA. "Currently some 75% of the methyl bromide used in the U.S. is applied to soils prior to planting, and another 11% is used on commodities to control pests after harvest. Without the good work agricultural scientists, like plant patholog
'"/>

Contact: Cindy Ash, Director of Scientific Services
cash@scisoc.org
612.454.7250
American Phytopathological Society
17-Feb-1998


Page: 1 2

Related biology news :

1. Phase II trials of second-generation antisense cancer drug planned following successful early study
2. OneWorld Health completes enrollment, treatment in Phase III India trial
3. Landmark, pivotal Phase IIb/III trial of biotoxin for cancer pain begins
4. VaxGen reports Phase I clinical trial results of anthrax vaccine candidate
5. Critical Therapeutics launches Phase I clinical trial of anti-inflammatory compound
6. KEPPRA international Phase IV SKATE study results show favourable efficacy
7. Phase III study results with Raptiva in the treatment of psoriasis presented at Annual AAD meeting
8. Phase III, 48-Wk NEAT study results comparing GW433908 to Nelfinavir presented today
9. OXiGENE announces commencement of Phase I/II clinical trial of Combretastatin A4 Prodrug
10. Acorda therapeutics receives NIH Phase 2 grant for central nervous system repair
11. Phase transition in bilayers could affect their performance

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/10/2020)... ... ... Today CJ BIO announced the first in a series of Food Ingredient MasterClass webinars, ... revolutionizing ingredient mixes, nutritional content and flavor profiles across a range of savory foods ... AM (CDT) during SHIFT20, the virtual edition of the IFT Annual Meeting & Food ...
(Date:7/1/2020)... ... 2020 , ... Cure Glioblastoma, a registered 501(c)(3) nonprofit research ... adult brain cancer—announced today the appointments of its first Senior Fellows: John Boockvar, ... organization’s initiatives and overall vision. , "Senior Fellows are more than advisors; they ...
(Date:6/23/2020)... ... June 23, 2020 , ... First Aid Africa, ... a UK supplier and manufacturer of innovative portable renewable energy equipment, have announced ... fight against the COVID-19 pandemic in Zambia. , One of Renovagen’s FAST FOLD ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International is ... $3950. With 50 million stem cells total, patients may choose which extremities they would ... for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue is ...
(Date:7/31/2020)... , ... July 29, 2020 , ... ... Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... that they have entered into a strategic partnership whereby Catalent will provide support ...
(Date:7/22/2020)... ... 22, 2020 , ... Join experts from Reed Tech , Gary Saner, ... a one hour live webinar on Thursday, August 13, 2020 at 11am ... and medical devices. Specifically, for medical devices, the NMPA has departments dealing with medical ...
(Date:7/18/2020)... ... 17, 2020 , ... dicentra , a leading Contract ... industries, is pleased to announce that Charles Galea has joined its clinical trials ... is an accomplished and results-driven sales executive with over 10 years of expertise ...
Breaking Biology Technology:
Cached News: